UniDoc Announces Amended LIFE Offering

Executive Summary

• UniDoc Health Corp. amended its previously announced non‑brokered private placement LIFE offering, setting a minimum raise of $800,000 (5,333,333 Units) and a maximum of $1.5 million (10,000,000 Units).
• Each Unit consists of one common share plus one transferable warrant to purchase an additional share at $0.25 for 36 months after closing.
• The offering is expected to close on or about October 22, 2025 (or within 45 days of the announcement) and will be used for inventory, marketing, investor‑relations services, working capital, and general corporate purposes.

Key Details

• Offering Size: Minimum $800,000; Maximum $1,500,000.
• Units Offered: Minimum 5,333,333 Units; Maximum 10,000,000 Units.
• Price per Unit: $0.15.
• Unit Composition: 1 common share + 1 transferable common‑share purchase warrant.
• Warrant Terms: Right to acquire one additional common share at $0.25 per share for a period of 36 months post‑closing.
• Use of Proceeds: Inventory, marketing and investor‑relations services, working capital, general corporate purposes.
• Exemption Used: Listed issuer financing exemption under Part 5A of NI 45‑106 (excluding Quebec).
• Closing Date: Expected on or about October 22, 2025; may occur within 45 days of the announcement.
• Conditions: Subject to customary closing conditions, including receipt of all necessary approvals (e.g., CSE approval).
• Documentation: Amended Offering Document available on SEDAR+ and company website.

Notable Quotes

• “The amendment provides greater flexibility for investors while ensuring we have sufficient capital to advance our eHealth solution.” – Antonio Baldassarre, CEO, President & Director, UniDoc Health Corp.